GENEDIT INC

Berkeley, CA · Biotech · Private

Non-viral CRISPR-Cas12a nanoparticle delivery system for gene editing

Grants
$225K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
35
3 granted · 32 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: A block copolymer delivery system for the Cpf1 ribonucleoprotein$225,000
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2506Kamau Therapeutics, Inc.—$5.0M
2507CONFLUENCE LIFE SCIENCES, INC.—$5.7M
2508Panorama Medicine Inc—$4.7M
2509GENEDIT INC——
2510DUO ONCOLOGY INC—$4.2M
2511Synthekine——
2512Skyhawk Therapeutics——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 3 granted of 35
  • Cationic Polymer And Use For Biomolecule Deliveryapplication
  • Cationic Polymer And Use For Biomolecule Deliverygranted
  • Cationic Polymer With Alkyl Side Chains And Use For Biomolecule Deliverygranted
  • Biodegradable Polymer Comprising Side Chains With Polyamine And Polyalkylene Oxide Groupsapplication
  • Polymer Comprising Multiple Functionalized Sidechains For Biomolecule Deliveryapplication
  • Cationic Polymer With Alkyl Side Chainsapplication
  • Structure-engineered Guide Rnagranted
  • Compositions And Methods For Target Nucleic Acid Modificationapplication
  • Compositions And Methods For Target Nucleic Acid Modificationapplication
  • Biodegradable Polymer Comprising Side Chains With Polyamine And Polyalkylene Oxide Groupsapplication
  • Polymer With Cationic And Hydrophobic Side Chainsapplication
  • SiRNA COMPOSITIONS TARGETING SCN9Aapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.